(株)ペルセウスプロテオミクスの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4882/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2021/10/29 | 日証協 | 77,411株 | +3.63% | 17,111株 | +249.2% | 223,181株 | -0.44% | 8,300株 | +29.49% |
| 2021/10/22 | 日証協 | 74,700株 | -22.91% | 4,900株 | -85.24% | 224,171株 | -4.64% | 6,410株 | -76.61% |
| 2021/10/15 | 日証協 | 96,900株 | +43.13% | 33,200株 | +526.42% | 235,071株 | +8.64% | 27,400株 | +124.31% |
| 2021/10/08 | 日証協 | 67,700株 | -10.45% | 5,300株 | -67.88% | 216,371株 | +1.84% | 12,215株 | +7.95% |
| 2021/10/01 | 日証協 | 75,600株 | -5.03% | 16,500株 | +1.23% | 212,456株 | -2.02% | 11,315株 | +28.58% |
| 2021/09/24 | 日証協 | 79,600株 | +12.43% | 16,300株 | +16.43% | 216,841株 | +2.02% | 8,800株 | -15.38% |
| 2021/09/17 | 日証協 | 70,800株 | +1.29% | 14,000株 | +218.18% | 212,541株 | -2.34% | 10,400株 | +26.83% |
| 2021/09/10 | 日証協 | 69,900株 | -5.54% | 4,400株 | -50% | 217,641株 | -2.68% | 8,200株 | -11.83% |
| 2021/09/03 | 日証協 | 74,000株 | +5.26% | 8,800株 | -11.11% | 223,641株 | +3.04% | 9,300株 | -4.12% |
| 2021/08/27 | 日証協 | 70,300株 | -19.06% | 9,900株 | -77.17% | 217,041株 | -7.68% | 9,700株 | -68.91% |
| 2021/08/20 | 日証協 | 86,859株 | +43.33% | 43,359株 | +290.62% | 235,100株 | +7.84% | 31,200株 | +246.67% |
| 2021/08/13 | 日証協 | 60,600株 | -30.02% | 11,100株 | -70.71% | 218,000株 | -6.12% | 9,000株 | -84.77% |
| 2021/08/06 | 日証協 | 86,600株 | -0.23% | 37,900株 | -73.46% | 232,200株 | +2.93% | 59,100株 | -49.62% |
| 2021/07/30 | 日証協 | 86,800株 | +85.47% | 142,800株 | +564.19% | 225,600株 | +15.28% | 117,300株 | +514.14% |
| 2021/07/21 | 日証協 | 46,800株 | +82.1% | 21,500株 | +150% | 195,700株 | +8.6% | 19,100株 | -52.72% |
| 2021/07/16 | 日証協 | 25,700株 | -26.36% | 8,600株 | -67.05% | 180,200株 | +12.55% | 40,400株 | -37.07% |
| 2021/07/09 | 日証協 | 34,900株 | -73.22% | 26,100株 | -86.86% | 160,100株 | +6.31% | 64,200株 | -55.2% |
| 2021/07/02 | 日証協 | 130,300株 | +2071.67% | 198,600株 | +183.31% | 150,600株 | +65.86% | 143,300株 | -0.07% |
| 2021/06/25 | 日証協 | 6,000株 | 0% | 70,100株 | 0% | 90,800株 | 0% | 143,400株 | 0% |
※株式分割は考慮していませんのでご注意ください。
Page Top